[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.189.139. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,177
Citations 0
Letters
May 22, 2013

Care for Transgender Persons

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Divisions of Endocrinology (Dr Danoff; ann.danoff@nyumc.org) and Infectious Diseases and Immunology (Drs Daskalakis and Aberg), New York University School of Medicine, New York, New York.

JAMA. 2013;309(20):2092-2093. doi:10.1001/jama.2013.4662

To the Editor: In a Clinical Crossroads article, Dr Spack1 reviewed key elements of psychological, hormonal, and surgical management of transgender and transsexual individuals. We suggest that testing for human immunodeficiency virus (HIV) also should be included as an integral component of transgender care.

Human immunodeficiency virus poses a significant threat to the health of transgender individuals. A meta-analysis of 29 studies estimated HIV infection rates of 11.8% to 27.7% among individuals seeking male-to-female (MTF) gender change (with nearly 73% unaware of their status at time of testing) and 0% to 3% among persons seeking female-to-male (FTM) gender change.2 Rates of HIV are 0.7% and 0.2% in gender-conforming males and females in the United States, respectively.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×